Skip to main content

Want a detailed portfolio tracker?

Passage Bio (PASG) P/E (2020 - 2026)

Passage Bio (PASG) P/E from Feb 28, 2020 to Jul 21, 2026. The TTM Passage Bio (PASG) P/E is -0.42. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Passage Bio (PASG)

YearP/EChange
2026-0.42-49.24%
2025-0.82+51.22%
2024-0.54+10.06%
2023-0.49+4.96%
2022-0.47-74.70%
2021-1.85-82.15%
2020-10.37N/A

Comparison Passage Bio (PASG) P/E with competitors

Passage Bio (PASG) P/E is -0.42.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.41%
NBYStablecoin Development Corp0.00-101.04%
ENLVEnlivex Ltd0.07-118.01%
FGENFibroGen Inc0.24-157.80%
CHRSCoherus Biosciences Inc0.85-304.33%
FBIOFortress Biotech Inc0.95-328.53%
ORMPOramed Pharmaceuticals Inc1.50-461.94%
AGENAgenus Inc3.01-824.72%
INVAInnoviva Inc3.15-859.50%
VXRTVaxart Inc3.55-954.79%
CRMDCorMedix Inc3.63-973.74%
CVACCureVac N.V.4.45-1170.53%
GLPGGalapagos NV4.86-1270.03%
SRPTSarepta Therapeutics Inc4.88-1275.62%
ABEOAbeona Therapeutics Inc5.39-1397.33%
ABUSArbutus Biopharma Corp5.60-1447.44%
ZVRAZevra Therapeutics Inc5.89-1517.66%
SPROSpero Therapeutics Inc6.23-1599.83%
CGENCompugen Ltd6.31-1620.42%
RIGLRigel Pharmaceuticals6.87-1754.81%
SLXNSilexion Therapeutics Corp7.30-1856.92%
OMEROmeros Corporation9.26-2329.54%
AUPHAurinia Pharmaceuticals Inc9.58-2408.09%
PLXProtalix BioTherapeutics Inc10.89-2722.59%
ACADAcadia Pharmaceuticals Inc11.73-2924.27%
TBPHTheravance Biopharma Inc12.26-3052.77%
ADMAAdma Biologics Inc12.42-3090.33%
HRMYHarmony Biosciences Holdings Inc13.82-3427.95%
SABSSAB Biotherapeutics Inc14.14-3504.05%
NAGENiagen Bioscience Inc14.82-3668.26%
INCYIncyte Corp15.82-3910.13%
REGNRegeneron Pharmaceuticals Inc15.86-3918.34%
PBYIPuma Biotechnology Inc17.32-4269.69%
CPRXCatalyst Pharmaceuticals Inc17.44-4299.45%
EXELExelixis Inc17.54-4323.22%
TGTXTG Therapeutics Inc18.97-4667.10%
MDXGMimedx Group Inc20.55-5049.13%
XOMAXOMA Royalty Corp22.87-5608.46%
ARGXArgen X SE24.30-5951.21%
CTMXCytomX Therapeutics Inc24.82-6077.18%
XOMAOXOMA Royalty Corp25.34-6203.29%
HALOHalozyme Therapeutics Inc25.62-6270.45%
XOMAPXOMA Royalty Corp25.67-6281.63%
VRTXVertex Pharmaceuticals Inc27.99-6841.42%
RPRXRoyalty Pharma plc - Class A28.69-7008.25%
SLNOSoleno Therapeutics Inc29.02-7087.19%
ASNDAscendis Pharma A/S30.09-7344.91%
LGNDLigand Pharmaceuticals Inc - Class B37.91-9229.60%
APLSApellis Pharmaceuticals Inc39.02-9496.71%
BMRNBiomarin Pharmaceutical Inc42.21-10265.05%
KRYSKrystal Biotech Inc45.34-11019.18%
ONCBeiGene Ltd69.54-16846.06%
PHARPharming Group N.V.75.03-18166.94%
TECHBio-Techne Corp101.96-24652.64%
VCELVericel Corp109.92-26570.21%
ALNYAlnylam Pharmaceuticals Inc117.96-28507.23%
GMABGenmab140.29-33883.49%
TLXTelix Pharmaceuticals Ltd162.15-39148.10%
CORTCorcept Therapeutics Inc212.86-51358.32%